Key regions: Japan, Italy, China, South Korea, Brazil
Iran, a country in Western Asia, has been hit hard by the COVID-19 pandemic. The country has been struggling to control the spread of the virus and has been actively seeking ways to mitigate the impact of the pandemic. In this context, the COVID-19 vaccines market in Iran has been developing rapidly.
Customer preferences: Iran has a large population of over 82 million people, and the government has been working to provide vaccines to as many people as possible. As a result, there has been a high demand for COVID-19 vaccines in the country. The government has been offering free vaccines to the public, and there has been a significant uptake of the vaccines. People have been willing to get vaccinated to protect themselves and their families from the virus.
Trends in the market: The COVID-19 vaccines market in Iran has been growing rapidly, with several vaccines being made available to the public. The government has been working to secure vaccines from various sources, including China, Russia, and India. The Sinopharm and Sputnik V vaccines have been the most widely used vaccines in the country. The government has also been working to produce its own vaccine, called COVIran Barekat. The vaccine has been developed by a local pharmaceutical company and has been approved for emergency use in the country. The government has been encouraging people to get vaccinated and has been working to increase the vaccination rate in the country.
Local special circumstances: Iran has been facing several challenges in its efforts to control the spread of the virus. The country has been under economic sanctions, which have made it difficult to access medical supplies and equipment. The sanctions have also affected the country's ability to produce its own vaccines. However, the government has been working to overcome these challenges and has been seeking help from other countries to secure vaccines and medical supplies.
Underlying macroeconomic factors: The COVID-19 pandemic has had a significant impact on the Iranian economy. The country has been facing a recession, and the pandemic has worsened the economic situation. The government has been working to mitigate the impact of the pandemic on the economy and has been providing financial assistance to businesses and individuals affected by the pandemic. The vaccination drive is expected to help the country recover from the pandemic and boost economic growth.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
